跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Approved
THERAPEUTIC
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
GENZYME IRELAND LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Apr 24, 2024
Approval ID
e6aca409c3954b7f
Company
GENZYME IRELAND LIMITED
Type
Therapeutic
Approval Details
Approval Id
e6aca409c3954b7f
Drug Name
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Product Name
NEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Approval Number
SIN16989P
Approval Date
2024-04-24
Registrant
SANOFI-AVENTIS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
A16AB22
Atc Item Name
avalglucosidase alfa
Pharma Manufacturer Name
SANOFI-AVENTIS SINGAPORE PTE. LTD.
Company Detail Path
/organization/sanofi-aventis-singapore-pte-ltd
Active Ingredients
AVALGLUCOSIDASE ALFA
100mg/vial
AVALGLUCOSIDASE ALFA
100mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 24, 2024
Approval ID
e6aca409c3954b7f
Type
Therapeutic
Back to HSA Approvals
